Copyright Reports & Markets. All rights reserved.

Global Preclinical Brain Imaging Market Size, Status and Forecast 2021-2027

Buy now

1 Report Overview

  • 1.1 Study Scope
  • 1.2 Market Analysis by Type
    • 1.2.1 Global Preclinical Brain Imaging Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
    • 1.2.2 Computed Tomography (CT)
    • 1.2.3 Positron Emission Tomography (PET)
    • 1.2.4 Magnetic Resonance Imaging (MRI)
    • 1.2.5 Single Photon Emission Computed Tomography (SPECT)
    • 1.2.6 Others
  • 1.3 Market by Application
    • 1.3.1 Global Preclinical Brain Imaging Market Share by Application: 2016 VS 2021 VS 2027
    • 1.3.2 Pharmaceutical Companies
    • 1.3.3 Contract Research Organization (CRO’s)
    • 1.3.4 Biotech Companies
    • 1.3.5 Others
  • 1.4 Study Objectives
  • 1.5 Years Considered

2 Global Growth Trends

  • 2.1 Global Preclinical Brain Imaging Market Perspective (2016-2027)
  • 2.2 Preclinical Brain Imaging Growth Trends by Regions
    • 2.2.1 Preclinical Brain Imaging Market Size by Regions: 2016 VS 2021 VS 2027
    • 2.2.2 Preclinical Brain Imaging Historic Market Share by Regions (2016-2021)
    • 2.2.3 Preclinical Brain Imaging Forecasted Market Size by Regions (2022-2027)
  • 2.3 Preclinical Brain Imaging Industry Dynamic
    • 2.3.1 Preclinical Brain Imaging Market Trends
    • 2.3.2 Preclinical Brain Imaging Market Drivers
    • 2.3.3 Preclinical Brain Imaging Market Challenges
    • 2.3.4 Preclinical Brain Imaging Market Restraints

3 Competition Landscape by Key Players

  • 3.1 Global Top Preclinical Brain Imaging Players by Revenue
    • 3.1.1 Global Top Preclinical Brain Imaging Players by Revenue (2016-2021)
    • 3.1.2 Global Preclinical Brain Imaging Revenue Market Share by Players (2016-2021)
  • 3.2 Global Preclinical Brain Imaging Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
  • 3.3 Players Covered: Ranking by Preclinical Brain Imaging Revenue
  • 3.4 Global Preclinical Brain Imaging Market Concentration Ratio
    • 3.4.1 Global Preclinical Brain Imaging Market Concentration Ratio (CR5 and HHI)
    • 3.4.2 Global Top 10 and Top 5 Companies by Preclinical Brain Imaging Revenue in 2020
  • 3.5 Preclinical Brain Imaging Key Players Head office and Area Served
  • 3.6 Key Players Preclinical Brain Imaging Product Solution and Service
  • 3.7 Date of Enter into Preclinical Brain Imaging Market
  • 3.8 Mergers & Acquisitions, Expansion Plans

4 Preclinical Brain Imaging Breakdown Data by Type

  • 4.1 Global Preclinical Brain Imaging Historic Market Size by Type (2016-2021)
  • 4.2 Global Preclinical Brain Imaging Forecasted Market Size by Type (2022-2027)

5 Preclinical Brain Imaging Breakdown Data by Application

  • 5.1 Global Preclinical Brain Imaging Historic Market Size by Application (2016-2021)
  • 5.2 Global Preclinical Brain Imaging Forecasted Market Size by Application (2022-2027)

6 North America

  • 6.1 North America Preclinical Brain Imaging Market Size (2016-2027)
  • 6.2 North America Preclinical Brain Imaging Market Size by Type
    • 6.2.1 North America Preclinical Brain Imaging Market Size by Type (2016-2021)
    • 6.2.2 North America Preclinical Brain Imaging Market Size by Type (2022-2027)
    • 6.2.3 North America Preclinical Brain Imaging Market Size by Type (2016-2027)
  • 6.3 North America Preclinical Brain Imaging Market Size by Application
    • 6.3.1 North America Preclinical Brain Imaging Market Size by Application (2016-2021)
    • 6.3.2 North America Preclinical Brain Imaging Market Size by Application (2022-2027)
    • 6.3.3 North America Preclinical Brain Imaging Market Size by Application (2016-2027)
  • 6.4 North America Preclinical Brain Imaging Market Size by Country
    • 6.4.1 North America Preclinical Brain Imaging Market Size by Country (2016-2021)
    • 6.4.2 North America Preclinical Brain Imaging Market Size by Country (2022-2027)
    • 6.4.3 United States
    • 6.4.3 Canada

7 Europe

  • 7.1 Europe Preclinical Brain Imaging Market Size (2016-2027)
  • 7.2 Europe Preclinical Brain Imaging Market Size by Type
    • 7.2.1 Europe Preclinical Brain Imaging Market Size by Type (2016-2021)
    • 7.2.2 Europe Preclinical Brain Imaging Market Size by Type (2022-2027)
    • 7.2.3 Europe Preclinical Brain Imaging Market Size by Type (2016-2027)
  • 7.3 Europe Preclinical Brain Imaging Market Size by Application
    • 7.3.1 Europe Preclinical Brain Imaging Market Size by Application (2016-2021)
    • 7.3.2 Europe Preclinical Brain Imaging Market Size by Application (2022-2027)
    • 7.3.3 Europe Preclinical Brain Imaging Market Size by Application (2016-2027)
  • 7.4 Europe Preclinical Brain Imaging Market Size by Country
    • 7.4.1 Europe Preclinical Brain Imaging Market Size by Country (2016-2021)
    • 7.4.2 Europe Preclinical Brain Imaging Market Size by Country (2022-2027)
    • 7.4.3 Germany
    • 7.4.4 France
    • 7.4.5 U.K.
    • 7.4.6 Italy
    • 7.4.7 Russia
    • 7.4.8 Nordic

8 Asia-Pacific

  • 8.1 Asia-Pacific Preclinical Brain Imaging Market Size (2016-2027)
  • 8.2 Asia-Pacific Preclinical Brain Imaging Market Size by Type
    • 8.2.1 Asia-Pacific Preclinical Brain Imaging Market Size by Type (2016-2021)
    • 8.2.2 Asia-Pacific Preclinical Brain Imaging Market Size by Type (2022-2027)
    • 8.2.3 Asia-Pacific Preclinical Brain Imaging Market Size by Type (2016-2027)
  • 8.3 Asia-Pacific Preclinical Brain Imaging Market Size by Application
    • 8.3.1 Asia-Pacific Preclinical Brain Imaging Market Size by Application (2016-2021)
    • 8.3.2 Asia-Pacific Preclinical Brain Imaging Market Size by Application (2022-2027)
    • 8.3.3 Asia-Pacific Preclinical Brain Imaging Market Size by Application (2016-2027)
  • 8.4 Asia-Pacific Preclinical Brain Imaging Market Size by Region
    • 8.4.1 Asia-Pacific Preclinical Brain Imaging Market Size by Region (2016-2021)
    • 8.4.2 Asia-Pacific Preclinical Brain Imaging Market Size by Region (2022-2027)
    • 8.4.3 China
    • 8.4.4 Japan
    • 8.4.5 South Korea
    • 8.4.6 Southeast Asia
    • 8.4.7 India
    • 8.4.8 Australia

9 Latin America

  • 9.1 Latin America Preclinical Brain Imaging Market Size (2016-2027)
  • 9.2 Latin America Preclinical Brain Imaging Market Size by Type
    • 9.2.1 Latin America Preclinical Brain Imaging Market Size by Type (2016-2021)
    • 9.2.2 Latin America Preclinical Brain Imaging Market Size by Type (2022-2027)
    • 9.2.3 Latin America Preclinical Brain Imaging Market Size by Type (2016-2027)
  • 9.3 Latin America Preclinical Brain Imaging Market Size by Application
    • 9.3.1 Latin America Preclinical Brain Imaging Market Size by Application (2016-2021)
    • 9.3.2 Latin America Preclinical Brain Imaging Market Size by Application (2022-2027)
    • 9.3.3 Latin America Preclinical Brain Imaging Market Size by Application (2016-2027)
  • 9.4 Latin America Preclinical Brain Imaging Market Size by Country
    • 9.4.1 Latin America Preclinical Brain Imaging Market Size by Country (2016-2021)
    • 9.4.2 Latin America Preclinical Brain Imaging Market Size by Country (2022-2027)
    • 9.4.3 Mexico
    • 9.4.4 Brazil

10 Middle East & Africa

  • 10.1 Middle East & Africa Preclinical Brain Imaging Market Size (2016-2027)
  • 10.2 Middle East & Africa Preclinical Brain Imaging Market Size by Type
    • 10.2.1 Middle East & Africa Preclinical Brain Imaging Market Size by Type (2016-2021)
    • 10.2.2 Middle East & Africa Preclinical Brain Imaging Market Size by Type (2022-2027)
    • 10.2.3 Middle East & Africa Preclinical Brain Imaging Market Size by Type (2016-2027)
  • 10.3 Middle East & Africa Preclinical Brain Imaging Market Size by Application
    • 10.3.1 Middle East & Africa Preclinical Brain Imaging Market Size by Application (2016-2021)
    • 10.3.2 Middle East & Africa Preclinical Brain Imaging Market Size by Application (2022-2027)
    • 10.3.3 Middle East & Africa Preclinical Brain Imaging Market Size by Application (2016-2027)
  • 10.4 Middle East & Africa Preclinical Brain Imaging Market Size by Country
    • 10.4.1 Middle East & Africa Preclinical Brain Imaging Market Size by Country (2016-2021)
    • 10.4.2 Middle East & Africa Preclinical Brain Imaging Market Size by Country (2022-2027)
    • 10.4.3 Turkey
    • 10.4.4 Saudi Arabia
    • 10.4.5 UAE

11 Key Players Profiles

  • 11.1 Aspect Imaging
    • 11.1.1 Aspect Imaging Company Details
    • 11.1.2 Aspect Imaging Business Overview
    • 11.1.3 Aspect Imaging Preclinical Brain Imaging Introduction
    • 11.1.4 Aspect Imaging Revenue in Preclinical Brain Imaging Business (2016-2021)
    • 11.1.5 Aspect Imaging Recent Development
  • 11.2 TriFoil Imaging
    • 11.2.1 TriFoil Imaging Company Details
    • 11.2.2 TriFoil Imaging Business Overview
    • 11.2.3 TriFoil Imaging Preclinical Brain Imaging Introduction
    • 11.2.4 TriFoil Imaging Revenue in Preclinical Brain Imaging Business (2016-2021)
    • 11.2.5 TriFoil Imaging Recent Development
  • 11.3 Caliber
    • 11.3.1 Caliber Company Details
    • 11.3.2 Caliber Business Overview
    • 11.3.3 Caliber Preclinical Brain Imaging Introduction
    • 11.3.4 Caliber Revenue in Preclinical Brain Imaging Business (2016-2021)
    • 11.3.5 Caliber Recent Development
  • 11.4 Pure Imaging Phantoms
    • 11.4.1 Pure Imaging Phantoms Company Details
    • 11.4.2 Pure Imaging Phantoms Business Overview
    • 11.4.3 Pure Imaging Phantoms Preclinical Brain Imaging Introduction
    • 11.4.4 Pure Imaging Phantoms Revenue in Preclinical Brain Imaging Business (2016-2021)
    • 11.4.5 Pure Imaging Phantoms Recent Development
  • 11.5 Bruker Corporation
    • 11.5.1 Bruker Corporation Company Details
    • 11.5.2 Bruker Corporation Business Overview
    • 11.5.3 Bruker Corporation Preclinical Brain Imaging Introduction
    • 11.5.4 Bruker Corporation Revenue in Preclinical Brain Imaging Business (2016-2021)
    • 11.5.5 Bruker Corporation Recent Development
  • 11.6 Mediso
    • 11.6.1 Mediso Company Details
    • 11.6.2 Mediso Business Overview
    • 11.6.3 Mediso Preclinical Brain Imaging Introduction
    • 11.6.4 Mediso Revenue in Preclinical Brain Imaging Business (2016-2021)
    • 11.6.5 Mediso Recent Development
  • 11.7 Spectral Instruments Imaging
    • 11.7.1 Spectral Instruments Imaging Company Details
    • 11.7.2 Spectral Instruments Imaging Business Overview
    • 11.7.3 Spectral Instruments Imaging Preclinical Brain Imaging Introduction
    • 11.7.4 Spectral Instruments Imaging Revenue in Preclinical Brain Imaging Business (2016-2021)
    • 11.7.5 Spectral Instruments Imaging Recent Development
  • 11.8 SIMTICS
    • 11.8.1 SIMTICS Company Details
    • 11.8.2 SIMTICS Business Overview
    • 11.8.3 SIMTICS Preclinical Brain Imaging Introduction
    • 11.8.4 SIMTICS Revenue in Preclinical Brain Imaging Business (2016-2021)
    • 11.8.5 SIMTICS Recent Development
  • 11.9 Biodex Medical Systems
    • 11.9.1 Biodex Medical Systems Company Details
    • 11.9.2 Biodex Medical Systems Business Overview
    • 11.9.3 Biodex Medical Systems Preclinical Brain Imaging Introduction
    • 11.9.4 Biodex Medical Systems Revenue in Preclinical Brain Imaging Business (2016-2021)
    • 11.9.5 Biodex Medical Systems Recent Development
  • 11.10 MR Solutions
    • 11.10.1 MR Solutions Company Details
    • 11.10.2 MR Solutions Business Overview
    • 11.10.3 MR Solutions Preclinical Brain Imaging Introduction
    • 11.10.4 MR Solutions Revenue in Preclinical Brain Imaging Business (2016-2021)
    • 11.10.5 MR Solutions Recent Development

12 Analyst's Viewpoints/Conclusions

    13 Appendix

    • 13.1 Research Methodology
      • 13.1.1 Methodology/Research Approach
      • 13.1.2 Data Source
    • 13.2 Disclaimer

    Preclinical Brain Imaging market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Preclinical Brain Imaging market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.

    Segment by Type
    Computed Tomography (CT)
    Positron Emission Tomography (PET)
    Magnetic Resonance Imaging (MRI)
    Single Photon Emission Computed Tomography (SPECT)
    Others

    Segment by Application
    Pharmaceutical Companies
    Contract Research Organization (CRO’s)
    Biotech Companies
    Others

    By Region
    North America
    U.S.
    Canada
    Europe
    Germany
    France
    U.K.
    Italy
    Russia
    Nordic
    Rest of Europe
    Asia-Pacific
    China
    Japan
    South Korea
    Southeast Asia
    India
    Australia
    Rest of Asia
    Latin America
    Mexico
    Brazil
    Rest of Latin America
    Middle East & Africa
    Turkey
    Saudi Arabia
    UAE
    Rest of MEA

    By Company
    Aspect Imaging
    TriFoil Imaging
    Caliber
    Pure Imaging Phantoms
    Bruker Corporation
    Mediso
    Spectral Instruments Imaging
    SIMTICS
    Biodex Medical Systems
    Pure Imaging Phantoms

    Buy now